Cache Advisors
PTGX icon

Cache Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Cache Advisors’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.43M Hold
10,143
– – 0.09% 66
2026
Q2 		$1.24M Hold
10,143
– – 0.11% 71
2026
Q1 		$1.07M Hold
10,143
– – 0.12% 50
2025
Q4 		$886K Hold
10,143
– – 0.11% 55
2025
Q3 		$674K Hold
10,143
– – 0.12% 59
2025
Q2 		$561K Hold
10,143
– – 0.15% 61
2025
Q1 		$491K Hold
10,143
– – 0.19% 56
2024
Q4 		$392K Buy
+10,143
New +$442K 0.16% 56

Other funds holding PTGX

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Franklin Street Advisors
Franklin Street Advisors Chapel Hill, North Carolina $1.82B AUM 22.19% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Cache Advisors's PTGX Position: Q3 2026 in Review

Cache Advisors held its Protagonist Therapeutics (PTGX) position steady in Q3 2026 at 10,143 shares worth $1.43M. The position accounts for 0.09% of the portfolio, ranked #66.

Cache Advisors first reported a position in PTGX in Q4 2024 and has held it in 8 quarters since. 39 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.

  • Cache Advisors held 10,143 shares of Protagonist Therapeutics worth $1.43M as of Q3 2026.
  • Cache Advisors left its Protagonist Therapeutics share count unchanged in Q3 2026.
  • Protagonist Therapeutics made up 0.09% of Cache Advisors's portfolio in Q3 2026, its #66 holding.
  • Cache Advisors first reported a position in Protagonist Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • 39 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.

Based on Cache Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.